arestin instructions
Arestin Instructions: A Comprehensive Guide (Updated April 21, 2026)
Arestin, celebrating 25 years of clinical use as of February 19, 2026, is the sole FDA-approved locally applied antibiotic. It’s utilized alongside scaling and root planing (SRP),
expanding access to periodontal care options.
What is Arestin?
Arestin (minocycline microspheres) represents a significant advancement in periodontal therapy. It’s a locally delivered antibiotic, meaning it’s applied directly into periodontal pockets – the spaces between the teeth and gums – during a routine dental visit. This targeted approach distinguishes Arestin from systemic antibiotics, which are taken orally and circulate throughout the entire body.

Approved by the Food and Drug Administration (FDA), Arestin has a notable history, marking a quarter-century of clinical use as of February 19, 2026. Developed by Bausch Health Companies Inc., it’s specifically designed to combat bacterial infection within these pockets, a primary cause of periodontal disease. The key benefit lies in its ability to deliver a concentrated dose of antibiotic precisely where it’s needed most, minimizing systemic exposure and potential side effects.
Furthermore, Arestin’s availability is expanding, improving access to treatment options and strengthening partnerships with dental professionals, particularly within underserved populations. It is always used in conjunction with scaling and root planing (SRP), a standard cleaning procedure.
Arestin’s Active Ingredient: Minocycline
The core component of Arestin is minocycline, a broad-spectrum tetracycline antibiotic. Unlike traditional minocycline formulations, Arestin utilizes a unique microsphere technology. These tiny spheres are composed of a biodegradable polymer, allowing for a sustained release of minocycline directly into the periodontal pocket over an extended period – up to 28 days.
Minocycline’s effectiveness stems from its ability to inhibit bacterial collagenase, an enzyme produced by bacteria that contributes to the breakdown of collagen and tissues supporting the teeth. By suppressing collagenase, minocycline helps to stabilize periodontal pockets and prevent further tissue destruction. The microsphere formulation ensures a concentrated, localized dose, maximizing its therapeutic impact.
This sustained release is crucial, as it maintains antibacterial levels within the pocket long after the initial application. This prolonged exposure helps to eliminate the bacteria responsible for periodontal inflammation and disease progression, offering a significant advantage over short-acting antibiotics.
How Arestin Works – Localized Antibiotic Delivery
Arestin’s innovative approach centers on localized antibiotic delivery. Traditional systemic antibiotics distribute throughout the body, potentially causing widespread effects and contributing to antibiotic resistance. Arestin, however, bypasses these concerns by directly targeting the source of infection – the periodontal pocket.
The microsphere formulation is key to this targeted delivery. Once applied into the pocket during a dental procedure, the biodegradable polymer spheres slowly release minocycline over 28 days. This sustained release creates a high concentration of antibiotic precisely where it’s needed, effectively combating the bacteria causing periodontal disease.
This localized approach minimizes systemic exposure, reducing the risk of side effects and the development of antibiotic resistance. By concentrating the antibiotic at the infection site, Arestin maximizes its effectiveness while minimizing its impact on the body’s overall microbiome. It’s a precision treatment for periodontal health.
Conditions Treated with Arestin
Arestin is primarily indicated for the treatment of chronic periodontitis, a severe gum infection that can damage the soft tissue and bone supporting teeth. It’s specifically designed to address localized aggressive periodontitis, where rapid progression of bone loss occurs. The antibiotic is used in conjunction with scaling and root planing (SRP) to enhance treatment outcomes.
Beyond chronic periodontitis, Arestin can be considered for patients exhibiting persistent inflammation and bleeding despite initial SRP therapy. It’s particularly beneficial in cases with deep periodontal pockets – spaces between the teeth and gums – that harbor harmful bacteria. The localized delivery helps eliminate these pathogens.
Dental professionals may also utilize Arestin for patients with a history of recurrent periodontal disease or those who haven’t responded adequately to conventional treatments. Expanding access to this treatment strengthens partnerships with dental professionals, offering improved care.
Periodontal Pockets and Arestin
Periodontal pockets are a key indicator of gum disease, forming when gums pull away from teeth, creating spaces susceptible to bacterial colonization. Arestin’s localized delivery system directly targets these pockets, releasing minocycline – its active ingredient – into the affected area. This concentrated approach maximizes antibiotic effectiveness where it’s needed most.
The depth of these pockets often dictates Arestin’s suitability; it’s commonly used in pockets 5-6 millimeters deep, and sometimes deeper, following scaling and root planing (SRP). By reaching these areas, Arestin disrupts the biofilm, a complex community of bacteria that contributes to inflammation and bone loss.
Arestin’s micro-encapsulated formulation ensures a prolonged release of minocycline over a period of up to 21 days, providing sustained antibacterial action. This extended effect helps control bacterial regrowth and supports gum tissue healing within the periodontal pockets.
Aggressive Periodontitis and Arestin Use
Aggressive periodontitis, a more severe form of gum disease, often requires a multi-faceted treatment approach. Arestin plays a crucial role in managing this condition, particularly when combined with scaling and root planing (SRP). Its localized antibiotic delivery helps control the rapid bacterial proliferation characteristic of aggressive forms.
Patients exhibiting signs of aggressive periodontitis – such as rapid attachment loss and bone destruction – may benefit significantly from Arestin. The targeted release of minocycline directly addresses the bacterial challenge within periodontal pockets, reducing inflammation and promoting tissue regeneration.
While Arestin isn’t a standalone cure for aggressive periodontitis, it serves as a valuable adjunct to SRP and, potentially, systemic antibiotics. Its ability to deliver a high concentration of antibiotic directly to the site of infection makes it a powerful tool in stabilizing the disease and preventing further progression. Careful monitoring and personalized treatment plans are essential.
Arestin Administration – The Procedure
Arestin administration is typically performed by a dentist or dental hygienist following a comprehensive periodontal examination. The procedure is generally quick and relatively comfortable, though local anesthesia may be used to minimize any potential discomfort. It’s always performed in conjunction with scaling and root planing (SRP), a thorough cleaning of the tooth surfaces.
The dentist will carefully measure periodontal pockets – the spaces between the teeth and gums – to determine the appropriate placement of Arestin. Using a specialized applicator, the micro-beads are gently inserted directly into these pockets. This ensures the antibiotic is delivered precisely where it’s needed most, targeting the harmful bacteria.
The entire process usually takes only a few minutes per quadrant of the mouth. Following Arestin placement, patients can typically resume their normal activities immediately, though specific post-treatment instructions will be provided to optimize healing and efficacy.
Preparation Before Arestin Application
Prior to Arestin application, a thorough periodontal evaluation is crucial. This includes a review of your dental and medical history, assessing your current oral health, and meticulously measuring the depths of your periodontal pockets. Your dentist will discuss your treatment plan and answer any questions you may have regarding Arestin and the overall procedure.
Crucially, scaling and root planing (SRP) – a deep cleaning to remove plaque and tartar both above and below the gumline – must be completed before Arestin is administered. SRP creates a cleaner environment, allowing Arestin to more effectively target remaining bacteria.
Inform your dentist about any allergies, medications you are taking, and any existing medical conditions, especially if you are pregnant or breastfeeding. This ensures your safety and helps tailor the treatment to your specific needs. A pre-treatment oral hygiene instruction session may also be provided to optimize the outcome.
Step-by-Step Arestin Application Process
The Arestin application is typically a swift, in-office procedure performed after scaling and root planing (SRP). First, the dentist will gently dry the periodontal pocket. Then, using a specialized applicator, the micro-beads of minocycline (Arestin’s active ingredient) are directly inserted into the pocket.
This targeted delivery system ensures a concentrated dose of antibiotic reaches the site of infection. The applicator is carefully advanced to the base of the pocket, and the Arestin is released as the applicator is slowly withdrawn. This process is repeated for each pocket requiring treatment.
No sutures are typically needed, and the procedure is generally well-tolerated. The entire application usually takes only a few minutes to complete, depending on the number of pockets being treated. Following application, your dentist may place a light dressing over the treated area.
Arestin and Scaling & Root Planing (SRP)
Arestin is never used as a standalone treatment; it’s always administered in conjunction with scaling and root planing (SRP). SRP is the foundational periodontal therapy, mechanically removing plaque and calculus (tartar) from tooth surfaces, both above and below the gumline. This creates a smoother surface, hindering further bacterial buildup.
However, SRP alone may not always eliminate all harmful bacteria, especially in deeper periodontal pockets. This is where Arestin steps in. By delivering a localized dose of minocycline directly into these pockets after SRP, Arestin targets the remaining bacteria that SRP couldn’t reach.
Think of SRP as the initial deep cleaning, and Arestin as the targeted antibiotic boost. This combined approach maximizes the effectiveness of periodontal treatment, promoting healing and preventing reinfection. Arestin’s FDA approval specifically highlights its use with SRP.

Post-Arestin Care Instructions
Following Arestin application, diligent post-operative care is crucial for optimal healing and treatment success. For the initial 24-48 hours, avoid disturbing the treated areas. This means refraining from brushing or flossing directly on the sites where Arestin was placed. Your dentist may recommend a modified brushing technique, focusing on other areas of your mouth.
A soft-bristled toothbrush is essential during this period. Avoid hard or abrasive foods that could irritate the gums. Stick to a softer diet, like yogurt, soup, or mashed potatoes. Over-the-counter pain relievers, such as ibuprofen or acetaminophen, can manage any mild discomfort.
It’s normal to experience some temporary tooth sensitivity or slight bleeding. However, contact your dentist if you experience severe pain, swelling, or fever. Maintaining excellent oral hygiene, as instructed by your dentist, is vital for long-term periodontal health.
Managing Discomfort After Treatment
Some discomfort following Arestin application is typical, but generally mild and manageable. Patients often report temporary tooth sensitivity to temperature or pressure, and slight soreness in the treated gum pockets. These sensations usually subside within a few days as the area heals and inflammation reduces.

Over-the-counter pain relievers, like ibuprofen (Advil, Motrin) or acetaminophen (Tylenol), are usually sufficient to alleviate any discomfort. Follow the dosage instructions on the medication label. Applying a cold compress to the cheek near the treated area for 15-20 minutes at a time, several times a day, can also help reduce swelling and pain.
Avoid strenuous activity for the first 24 hours. If discomfort persists beyond a few days, or if it worsens, contact your dentist. They can assess the situation and provide further guidance or prescribe stronger pain relief if necessary.

Dietary Recommendations Post-Arestin
Following Arestin application, a soft food diet is recommended for the first 24-48 hours to minimize irritation to the treated gum tissues. Avoid hard, crunchy, or chewy foods that could potentially disrupt the antibiotic placement or cause discomfort. This includes items like nuts, chips, steak, and sticky candies.
Opt for foods that are easy to chew and swallow, such as yogurt, soup, mashed potatoes, scrambled eggs, smoothies, and well-cooked pasta. Ensure your diet remains nutritionally balanced to support healing. Hydration is also crucial; drink plenty of water to keep your mouth moist and promote tissue repair.
Avoid extremely hot or cold foods and beverages, as these can exacerbate tooth sensitivity. Limit sugary foods and drinks, as they can contribute to bacterial growth. Gradually reintroduce your normal diet as your gums heal and sensitivity decreases.
Oral Hygiene Following Arestin Application
Maintaining excellent oral hygiene is paramount after Arestin treatment, but requires a gentle approach. For the initial 24-48 hours, avoid brushing directly on the treated areas to prevent dislodging the antibiotic microspheres. Continue brushing other areas of your mouth as usual, using a soft-bristled toothbrush.
Gentle flossing is permitted, but carefully avoid the treated pockets. Your dentist may recommend a special mouthwash, such as chlorhexidine gluconate, to further reduce bacteria and promote healing. Avoid alcohol-based mouthwashes, as they can cause dryness and irritation.
After 48 hours, you can gradually resume normal brushing and flossing around the treated areas, but continue to be gentle. Regular dental check-ups and professional cleanings are essential for long-term periodontal health. Consistent oral hygiene reinforces Arestin’s benefits and prevents recurrence of infection.
Arestin Side Effects
While Arestin is generally well-tolerated, some side effects can occur. It’s crucial to be aware of these and report any concerns to your dentist promptly. Most side effects are mild and temporary, resolving within a few days of treatment.
Common side effects include localized pain, swelling, bleeding, or bruising at the application site. Some patients may experience temporary taste alterations or discoloration of the gums. These are typically minor and don’t require intervention.

Rare but serious side effects, though uncommon, can include systemic antibiotic reactions like allergic responses. These require immediate medical attention. It’s vital to inform your dentist of any allergies before treatment. Reporting any unusual symptoms ensures appropriate management and monitoring. Your dentist will discuss potential risks and benefits before proceeding with Arestin application.

Common Side Effects of Arestin
Following Arestin application, patients frequently experience mild and transient side effects. These are generally localized to the treatment area and resolve independently within a short timeframe, typically a few days. Localized pain is perhaps the most common complaint, often described as a dull ache or sensitivity.
Minor bleeding from the treated pockets is also typical, especially immediately after the procedure. Swelling around the gums and teeth may occur, but it’s usually minimal. Some individuals report temporary bruising at the injection sites. A transient metallic taste or a slight alteration in taste perception can also be experienced.
Temporary discoloration of the gums, appearing as a brownish hue, is possible due to the minocycline component. This discoloration is harmless and fades over time. These common side effects are generally manageable and don’t necessitate specific treatment, but should be reported to your dentist.
Rare but Serious Side Effects
Although uncommon, Arestin can, in rare instances, cause more serious side effects requiring immediate medical attention. Severe allergic reactions, characterized by hives, swelling of the face, lips, tongue, or throat, and difficulty breathing, are possible, though extremely rare.
Angioedema, a more severe form of swelling, can also occur. Tooth discoloration, while typically temporary, has been reported as persistent in isolated cases. Infection at the application site, though minimized by proper technique, remains a potential risk.
Drug reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, are exceedingly rare but potentially life-threatening. Symptoms include fever, rash, swollen lymph nodes, and internal organ involvement. Hypersensitivity to minocycline can manifest in various ways. Any unusual or severe symptoms following Arestin treatment should be promptly reported to your dentist or a medical professional.
Reporting Side Effects to Your Dentist
Open communication with your dentist is crucial following Arestin treatment. Promptly report any adverse reactions, even if they seem minor, as early detection can prevent complications. Document the onset, duration, and severity of any symptoms you experience.
Specifically inform your dentist about any signs of allergic reaction – hives, swelling, difficulty breathing – or unusual discomfort at the application site. Detail any changes in your oral health, such as persistent pain, bleeding, or tooth discoloration.
Your dentist will assess your symptoms and determine the appropriate course of action, which may include medication, further evaluation, or supportive care. Don’t hesitate to reach out with questions or concerns, even after your initial post-treatment check-up. Accurate reporting aids in monitoring Arestin’s safety profile and optimizing patient care. Maintaining a detailed record of your experience is highly recommended.
Arestin and Patient Suitability
Determining if Arestin is appropriate involves a thorough evaluation of your periodontal health and medical history. Ideal candidates typically have chronic periodontitis with persistent periodontal pockets, even after scaling and root planing (SRP). Your dentist will assess pocket depth, bleeding on probing, and attachment loss.
Factors considered include your overall health, any allergies, and current medications. Patients with compromised immune systems or certain medical conditions may require special consideration. A comprehensive review ensures Arestin’s benefits outweigh potential risks.
It’s essential to disclose all relevant medical information to your dentist. Arestin isn’t a one-size-fits-all solution; suitability is individualized. Careful patient selection maximizes treatment success and minimizes adverse events. Discuss any concerns you have with your dental professional to determine if Arestin is the right option for you.
Contraindications for Arestin Use
While generally safe, Arestin isn’t suitable for all patients. Absolute contraindications include known hypersensitivity to minocycline or any of the product’s components. Patients with a history of severe allergic reactions to tetracycline antibiotics should avoid Arestin.
Relative contraindications require careful consideration. These include patients with a compromised immune system, as the localized antibiotic effect could potentially lead to systemic absorption and complications. Similarly, individuals with renal or hepatic impairment may experience altered drug metabolism.
Arestin is generally avoided in patients with active periodontal infections extending beyond localized pockets, such as aggressive or rapidly progressing periodontitis. Your dentist will assess your medical history and periodontal condition to determine if any contraindications exist. Open communication is crucial to ensure safe and effective treatment.
Arestin for Pregnant or Breastfeeding Patients
The use of Arestin during pregnancy and breastfeeding requires careful evaluation and discussion with your dentist and obstetrician. Minocycline, the active ingredient, can cross the placental barrier and may affect fetal skeletal development, particularly during the second and third trimesters. Therefore, Arestin is generally avoided during pregnancy unless the potential benefits clearly outweigh the risks.
Regarding breastfeeding, minocycline is excreted in human milk. While the clinical significance of this is not fully established, caution is advised. The American Academy of Pediatric Dentistry recommends considering alternative treatments whenever possible during lactation. Your dentist will thoroughly assess your individual circumstances and provide personalized recommendations.
Postponing Arestin treatment until after pregnancy and breastfeeding is often the preferred approach. However, if periodontal health significantly impacts overall health, a risk-benefit analysis will be conducted to determine the most appropriate course of action.
Arestin and Patients with Allergies

Patients with known allergies, particularly to tetracycline-class antibiotics like minocycline, must inform their dentist before Arestin application. Arestin’s active ingredient, minocycline, can trigger allergic reactions in sensitive individuals, ranging from mild skin rashes to severe anaphylaxis. A thorough medical history review is crucial to identify potential allergies.

If a patient has a history of allergic reactions to other tetracyclines, a sensitivity test may be considered, although its reliability isn’t absolute. The dentist will carefully weigh the risks and benefits before proceeding with Arestin treatment. Alternative antibiotic therapies or non-antibiotic periodontal treatments may be recommended for patients with confirmed minocycline allergies.
It’s also important to disclose any allergies to local anesthetics or other dental materials, as these could potentially interact with Arestin or complicate the treatment process. Promptly reporting any signs of an allergic reaction during or after Arestin application is vital.
Arestin’s Efficacy and Clinical Studies
Arestin’s effectiveness has been demonstrated through extensive clinical research spanning 25 years, solidifying its position as a trusted periodontal therapy. Studies consistently show that Arestin, when used adjunctively with scaling and root planing (SRP), significantly improves clinical outcomes compared to SRP alone.
These studies reveal reductions in probing depths, attachment levels, and bleeding on probing, indicating improved periodontal health. Long-term success rates demonstrate sustained benefits, with patients experiencing fewer instances of periodontal pocket recurrence. Clinical trials have compared Arestin to systemic antibiotics, revealing comparable efficacy with the advantage of localized delivery and reduced systemic exposure.
The localized application minimizes systemic side effects, a key benefit over oral antibiotics. Ongoing research continues to evaluate Arestin’s role in various periodontal conditions and refine treatment protocols, ensuring its continued relevance in modern periodontal care.
Long-Term Success Rates with Arestin
Arestin demonstrates impressive long-term success in managing periodontal disease, supported by 25 years of clinical data. Studies tracking patients for several years post-treatment reveal sustained improvements in key periodontal parameters, including reduced probing depths and attachment loss.
Patients receiving Arestin alongside scaling and root planing (SRP) exhibit significantly lower rates of pocket recurrence compared to those treated with SRP alone. Longitudinal analyses show that the benefits of Arestin extend beyond the initial treatment phase, contributing to long-term periodontal stability.
Maintenance therapy, combined with Arestin’s initial application, further enhances these positive outcomes. Clinical observations indicate that Arestin helps to create a more favorable environment for tissue regeneration and prevents the re-establishment of harmful bacterial colonies. These consistent results underscore Arestin’s value as a durable solution for periodontal health.
Arestin vs. Systemic Antibiotics
Arestin offers a distinct advantage over systemic antibiotics in periodontal treatment due to its localized delivery of minocycline. Unlike oral antibiotics, which circulate throughout the entire body, Arestin targets the infection directly within periodontal pockets.
This targeted approach minimizes systemic exposure, reducing the risk of widespread side effects like gastrointestinal upset or antibiotic resistance development. Systemic antibiotics can disrupt the body’s natural microbiome, while Arestin’s localized action preserves beneficial bacteria elsewhere.
Furthermore, Arestin achieves higher concentrations of the antibiotic at the site of infection compared to systemic administration. Clinical studies demonstrate that this focused delivery enhances treatment efficacy and promotes faster healing. Arestin represents a more precise and patient-friendly alternative to broad-spectrum antibiotic regimens for periodontal disease.

The 25-Year History of Arestin Clinical Use
Arestin, as of February 19, 2026, proudly marks a quarter-century – 25 years – of dedicated clinical application in periodontal therapy. Introduced as a groundbreaking locally applied antibiotic, it revolutionized the treatment of periodontal pockets alongside scaling and root planing (SRP).
Throughout these years, Arestin has consistently demonstrated efficacy and safety, becoming a cornerstone in the fight against gum disease. Extensive clinical research and real-world application have solidified its position as a trusted treatment option for dentists and periodontists.
Bausch Health Companies Inc. continues to support Arestin’s evolution, expanding access to treatment and strengthening partnerships within the dental community. This longevity underscores Arestin’s enduring value and commitment to improving periodontal health for patients worldwide, with ongoing advancements and refinements expected in the years to come.


























































































